AEterna Zentaris Inc (AEZS)
2.19
+0.11
(+5.29%)
USD |
NASDAQ |
Mar 28, 16:00
2.17
-0.02
(-0.91%)
After-Hours: 20:00
AEterna Zentaris Price: 2.19 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 28, 2024 | 2.05 | 2.19 | 2.01 | 2.19 | 49506.00 |
Mar 27, 2024 | 1.97 | 2.10 | 1.97 | 2.08 | 22949.00 |
Mar 26, 2024 | 1.98 | 2.09 | 1.98 | 2.00 | 9059.00 |
Mar 25, 2024 | 1.99 | 2.08 | 1.99 | 1.99 | 4236.00 |
Mar 22, 2024 | 1.96 | 2.07 | 1.96 | 2.07 | 4678.00 |
Mar 21, 2024 | 2.00 | 2.13 | 1.96 | 1.97 | 19177.00 |
Mar 20, 2024 | 2.10 | 2.15 | 2.04 | 2.07 | 25677.00 |
Mar 19, 2024 | 2.17 | 2.20 | 2.05 | 2.11 | 16673.00 |
Mar 18, 2024 | 2.14 | 2.17 | 2.04 | 2.10 | 17867.00 |
Mar 15, 2024 | 1.99 | 2.24 | 1.980 | 2.17 | 44256.00 |
Mar 14, 2024 | 2.09 | 2.09 | 1.960 | 2.00 | 13222.00 |
Mar 13, 2024 | 2.00 | 2.095 | 1.90 | 2.045 | 26617.00 |
Mar 12, 2024 | 1.95 | 2.39 | 1.89 | 2.04 | 204986.0 |
Mar 11, 2024 | 1.94 | 1.94 | 1.85 | 1.88 | 5728.00 |
Mar 08, 2024 | 1.88 | 1.97 | 1.85 | 1.90 | 6023.00 |
Mar 07, 2024 | 1.87 | 1.970 | 1.83 | 1.85 | 20497.00 |
Mar 06, 2024 | 1.960 | 1.98 | 1.89 | 1.89 | 31343.00 |
Mar 05, 2024 | 1.85 | 1.92 | 1.85 | 1.90 | 6204.00 |
Mar 04, 2024 | 1.96 | 1.96 | 1.852 | 1.90 | 7399.00 |
Mar 01, 2024 | 1.94 | 1.98 | 1.876 | 1.90 | 7714.00 |
Feb 29, 2024 | 1.91 | 1.960 | 1.85 | 1.91 | 14361.00 |
Feb 28, 2024 | 1.883 | 1.90 | 1.85 | 1.87 | 5388.00 |
Feb 27, 2024 | 1.93 | 2.00 | 1.85 | 1.91 | 23486.00 |
Feb 26, 2024 | 1.88 | 1.98 | 1.85 | 1.95 | 23264.00 |
Feb 23, 2024 | 1.70 | 1.89 | 1.70 | 1.89 | 30114.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.42
Minimum
Nov 02 2023
135.75
Maximum
Apr 04 2019
17.65
Average
9.98
Median
Nov 30 2020
Price Benchmarks
Acasti Pharma Inc | 3.425 |
Aurinia Pharmaceuticals Inc | 5.005 |
Edesa Biotech Inc | 4.192 |
Lexaria Bioscience Corp | 3.63 |
Xenon Pharmaceuticals Inc | 43.05 |
Price Related Metrics
PS Ratio | 1.550 |
PEG Ratio | -0.006 |
Price to Book Value | 0.4047 |
Earnings Yield | -219.6% |
Market Cap | 10.63M |
PEGY Ratio | -0.006 |